Forest Baskett - Net Worth and Insider Trading
Forest Baskett Net Worth
The estimated net worth of Forest Baskett is at least $4.1 Billion dollars as of 2024-04-27. Forest Baskett is the Director of Robinhood Markets Inc and owns about 47,664,751 shares of Robinhood Markets Inc (HOOD) stock worth over $852 Million. Forest Baskett is the 10% Owner of Tesaro Inc and owns about 10,420,645 shares of Tesaro Inc (TSRO) stock worth over $781 Million. Forest Baskett is also the Director, 10% Owner of iShares Indl/Office Real Estate Capped and owns about 13,603,013 shares of iShares Indl/Office Real Estate Capped (FNIO) stock worth over $434 Million. Besides these, Forest Baskett also holds Cloudflare Inc (NET) , Arcellx Inc (ACLX) , Supernus Pharmaceuticals Inc (SUPN) , Rhythm Pharmaceuticals Inc (RYTM) , Ra Pharmaceuticals Inc (RARX) , Echo Global Logistics Inc (ECHO) , Adaptimmune Therapeutics PLC (ADAP) , Savara Inc (SVRA) , Mirum Pharmaceuticals Inc (MIRM) , Ardelyx Inc (ARDX) , Korro Bio Inc (KRRO) , AVEO Pharmaceuticals Inc (AVEO) , Akouos Inc (AKUS) , Groupon Inc (GRPN) , Liquidia Corp (LQDA) , Trevi Therapeutics Inc (TRVI) , Mersana Therapeutics Inc (MRSN) , InnerWorkings Inc (INWK) , Millennial Media Inc (MM) , Inozyme Pharma Inc (INZY) , Epizyme Inc (EPZM) , Marker Therapeutics Inc (MRKR) , Surface Oncology Inc (SURF) , Regulus Therapeutics Inc (RGLS) , Eargo Inc (EAR) , Dermira Inc (DERM) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , Clovis Oncology Inc (CLVSQ) , TRACON Pharmaceuticals Inc (TCON) , Metacrine Inc (MTCR) , ARCA biopharma Inc (ABIO) , Genocea Biosciences Inc (GNCAQ) , Tableau Software Inc (DATA) , ARYx Therapeutics Inc (ARYX) , Appian Corp (APPN) . Details can be seen in Forest Baskett's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Forest Baskett has not made any transactions after 2024-04-22 and currently still holds the listed stock(s).
Transaction Summary of Forest Baskett
Forest Baskett Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Forest Baskett owns 95 companies in total, including Eargo Inc (EAR) , Metacrine Inc (MTCR) , and Mersana Therapeutics Inc (MRSN) among others .
Click here to see the complete history of Forest Baskett’s form 4 insider trades.
Insider Ownership Summary of Forest Baskett
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
EAR | Eargo Inc | 2020-10-20 | 10 percent owner |
MTCR | Metacrine Inc | 2021-12-22 | 10 percent owner |
MRSN | Mersana Therapeutics Inc | 2020-04-13 | 10 percent owner |
NET | Cloudflare Inc | 2020-11-11 | 10 percent owner |
SPT | Sprout Social Inc | 2019-12-12 | 10 percent owner |
INZY | Inozyme Pharma Inc | 2020-07-28 | 10 percent owner |
GNCAQ | Genocea Biosciences Inc | 2022-05-25 | 10 percent owner |
ANNX | Annexon Inc | 2020-07-23 | 10 percent owner |
NKTX | Nkarta Inc | 2020-07-09 | 10 percent owner |
AKUS | Akouos Inc | 2020-06-30 | 10 percent owner |
AVEO | AVEO Pharmaceuticals Inc | 2020-06-19 | 10 percent owner |
ARDX | Ardelyx Inc | 2021-12-15 | 10 percent owner |
SURF | Surface Oncology Inc | 2018-04-23 | 10 percent owner |
TRVI | Trevi Therapeutics Inc | 2022-04-11 | 10 percent owner |
RARX | Ra Pharmaceuticals Inc | 2020-04-02 | 10 percent owner |
IMRA | Imara Inc | 2020-03-11 | 10 percent owner |
CSBR | Champions Oncology Inc | 2015-03-11 | 10 percent owner |
CSPR | Casper Sleep Inc | 2020-02-06 | 10 percent owner |
BDTX | Black Diamond Therapeutics Inc | 2020-01-29 | 10 percent owner |
ADAP | Adaptimmune Therapeutics PLC | 2020-01-24 | 10 percent owner |
RGLS | Regulus Therapeutics Inc | 2020-12-04 | 10 percent owner |
PTI | Proteostasis Therapeutics Inc | 2019-11-26 | 10 percent owner |
GRTX | Galera Therapeutics Inc | 2019-11-06 | 10 percent owner |
OYST | Oyster Point Pharma Inc | 2019-10-30 | 10 percent owner |
MIRM | Mirum Pharmaceuticals Inc | 2019-07-22 | 10 percent owner |
NITE | Nightstar Therapeutics PLC | 2019-06-07 | 10 percent owner |
TSRO | Tesaro Inc | 2019-01-22 | 10 percent owner |
MLND | Millendo Therapeutics Inc | 2018-12-07 | 10 percent owner |
PHASQ | PhaseBio Pharmaceuticals Inc | 2018-10-17 | 10 percent owner |
MRKR | Marker Therapeutics Inc | 2021-03-16 | 10 percent owner |
ESTC | Elastic NV | 2018-10-04 | 10 percent owner |
LQDA | Liquidia Corp | 2018-07-30 | 10 percent owner |
MULE | MuleSoft Inc | 2018-05-01 | 10 percent owner |
TCON | TRACON Pharmaceuticals Inc | 2018-03-27 | 10 percent owner |
CASC | Cascadian Therapeutics Inc | 2018-03-09 | 10 percent owner |
ABIO | ARCA biopharma Inc | 2018-02-26 | 10 percent owner |
TNTRQ | Tintri Inc | 2018-02-26 | 10 percent owner |
APPN | Appian Corp | 2017-11-27 | 10 percent owner |
SYBX | Synlogic Inc | 2015-09-30 | 10 percent owner |
SBBP | Strongbridge Biopharma PLC | 2018-01-01 | 10 percent owner |
XFOR | X4 Pharmaceuticals Inc | 2017-11-20 | 10 percent owner |
CRCM | Care.com Inc | 2017-11-06 | 10 percent owner |
RYTM | Rhythm Pharmaceuticals Inc | 2017-10-10 | 10 percent owner |
ZSANQ | Zosano Pharma Corp | 2015-01-26 | 10 percent owner |
AKAOQ | Achaogen Inc | 2016-12-19 | 10 percent owner |
DATA | Tableau Software Inc | 2016-12-05 | director |
ROKA | Sorrento Tech Inc | 2016-09-21 | 10 percent owner |
ILIU | Interleukin Genetics Inc | 2016-07-29 | 10 percent owner |
OPWR | Opower Inc | 2016-06-14 | 10 percent owner |
TRIV | TriVascular Technologies Inc | 2016-02-03 | 10 percent owner |
EPZM | Epizyme Inc | 2016-01-12 | 10 percent owner |
SUPN | Supernus Pharmaceuticals Inc | 2015-06-17 | 10 percent owner |
AVTX | Avalo Therapeutics Inc | 2015-10-14 | 10 percent owner |
BOX | Box Inc | 2015-01-22 | 10 percent owner |
TRVN | Trevena Inc | 2014-01-30 | 10 percent owner |
CVT | Cvent Inc | 2014-11-25 | 10 percent owner |
DERM | Dermira Inc | 2014-10-08 | 10 percent owner |
SNSS | Sunesis Pharmaceuticals Inc | 2014-08-27 | 10 percent owner |
LOXO | Loxo Oncology Inc | 2014-08-06 | 10 percent owner |
HIVE | Aerohive Networks Inc | 2014-04-02 | 10 percent owner |
ECOM | ChannelAdvisor Corp | 2013-05-22 | 10 percent owner |
GLYC | GlycoMimetics Inc | 2014-01-09 | 10 percent owner |
XOOM | Xoom Corp | 2013-10-29 | 10 percent owner |
GRPN | Groupon Inc | 2013-08-15 | 10 percent owner |
CLVSQ | Clovis Oncology Inc | 2011-11-21 | 10 percent owner |
WDAY | Workday Inc | 2012-10-11 | 10 percent owner |
MM | Millennial Media Inc | 2012-10-29 | 10 percent owner |
INWK | InnerWorkings Inc | 2012-03-28 | 10 percent owner |
FOLD | Amicus Therapeutics Inc | 2007-05-30 | 10 percent owner |
ECHO | Echo Global Logistics Inc | 2009-10-01 | 10 percent owner |
ARYX | ARYx Therapeutics Inc | 2011-03-10 | 10 percent owner |
VIRX | Viracta Therapeutics Inc | 2009-04-03 | 10 percent owner |
SVRA | Savara Inc | 2023-07-17 | 10 percent owner |
YMTX | Yumanity Therapeutics Inc | 2016-02-10 | 10 percent owner |
UTRS | Minerva Surgical Inc | 2021-10-21 | 10 percent owner |
TPST | Tempest Therapeutics Inc | 2018-12-07 | 10 percent owner |
RPHM | Reneo Pharmaceuticals Inc | 2021-04-08 | 10 percent owner |
COUR | Coursera Inc | 2021-03-30 | 10 percent owner |
VRNA | Verona Pharma PLC | 2021-01-01 | 10 percent owner |
NEUE | NeueHealth Inc | 2021-06-24 | 10 percent owner |
DM | Desktop Metal Inc | 2020-12-09 | 10 percent owner |
HOOD | Robinhood Markets Inc | 2022-01-31 | director & 10 percent owner |
ACLX | Arcellx Inc | 2022-12-22 | 10 percent owner |
BGRY | Berkshire Grey Inc | 2021-07-21 | 10 percent owner |
IONQ | IonQ Inc | 2021-09-30 | 10 percent owner |
GLUE | Monte Rosa Therapeutics Inc | 2021-06-23 | 10 percent owner |
BZFD | BuzzFeed Inc | 2021-12-03 | 10 percent owner |
SNTI | Senti Biosciences Inc | 2022-06-08 | 10 percent owner |
ZFOX | ZeroFox Holdings Inc | 2022-08-03 | 10 percent owner |
KA | Kineta Inc | 2016-02-10 | 10 percent owner |
ELVN | Enliven Therapeutics Inc | 2020-03-11 | 10 percent owner |
GGNNQ | Genocea Biosciences Inc | 2018-01-19 | 10 percent owner |
SGMT | Sagimet Biosciences Inc | 2023-07-13 | 10 percent owner |
RAACU | Revolution Acceleration Acquisition Corp | 2021-07-21 | 10 percent owner |
KRRO | Korro Bio Inc | 2024-04-22 | 10 percent owner |
Forest Baskett Latest Holdings Summary
Forest Baskett currently owns a total of 39 stocks. Among these stocks, Forest Baskett owns 47,664,751 shares of Robinhood Markets Inc (HOOD) as of January 31, 2022, with a value of $852 Million and a weighting of 20.69%. Forest Baskett owns 10,420,645 shares of Tesaro Inc (TSRO) as of March 6, 2018, with a value of $781 Million and a weighting of 18.97%. Forest Baskett also owns 13,603,013 shares of iShares Indl/Office Real Estate Capped (FNIO) as of May 1, 2012, with a value of $434 Million and a weighting of 10.53%. The other 36 stocks Cloudflare Inc (NET) , Arcellx Inc (ACLX) , Supernus Pharmaceuticals Inc (SUPN) , Rhythm Pharmaceuticals Inc (RYTM) , Ra Pharmaceuticals Inc (RARX) , Echo Global Logistics Inc (ECHO) , Adaptimmune Therapeutics PLC (ADAP) , Savara Inc (SVRA) , Mirum Pharmaceuticals Inc (MIRM) , Ardelyx Inc (ARDX) , Korro Bio Inc (KRRO) , AVEO Pharmaceuticals Inc (AVEO) , Akouos Inc (AKUS) , Groupon Inc (GRPN) , Liquidia Corp (LQDA) , Trevi Therapeutics Inc (TRVI) , Mersana Therapeutics Inc (MRSN) , InnerWorkings Inc (INWK) , Millennial Media Inc (MM) , Inozyme Pharma Inc (INZY) , Epizyme Inc (EPZM) , Marker Therapeutics Inc (MRKR) , Surface Oncology Inc (SURF) , Regulus Therapeutics Inc (RGLS) , Eargo Inc (EAR) , Dermira Inc (DERM) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , Clovis Oncology Inc (CLVSQ) , TRACON Pharmaceuticals Inc (TCON) , Metacrine Inc (MTCR) , ARCA biopharma Inc (ABIO) , Genocea Biosciences Inc (GNCAQ) , Tableau Software Inc (DATA) , ARYx Therapeutics Inc (ARYX) , Appian Corp (APPN) have a combined weighting of 49.81% among all his current holdings.
Latest Holdings of Forest Baskett
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HOOD | Robinhood Markets Inc | 2022-01-31 | 47,664,751 | 17.88 | 852,245,748 |
TSRO | Tesaro Inc | 2018-03-06 | 10,420,645 | 74.96 | 781,131,549 |
FNIO | iShares Indl/Office Real Estate Capped | 2012-05-01 | 13,603,013 | 31.89 | 433,800,085 |
NET | Cloudflare Inc | 2020-11-11 | 3,842,216 | 88.01 | 338,153,430 |
ACLX | Arcellx Inc | 2022-12-22 | 4,745,262 | 51.92 | 246,374,003 |
SUPN | Supernus Pharmaceuticals Inc | 2015-06-17 | 7,641,250 | 30.07 | 229,772,388 |
RYTM | Rhythm Pharmaceuticals Inc | 2017-10-10 | 4,909,956 | 38.28 | 187,953,116 |
RARX | Ra Pharmaceuticals Inc | 2016-10-31 | 3,490,073 | 47.99 | 167,488,603 |
ECHO | Echo Global Logistics Inc | 2009-10-01 | 2,420,219 | 48.24 | 116,751,365 |
ADAP | Adaptimmune Therapeutics PLC | 2020-01-24 | 102,478,668 | 1.08 | 110,164,568 |
SVRA | Savara Inc | 2023-07-17 | 24,471,264 | 4.41 | 107,918,274 |
MIRM | Mirum Pharmaceuticals Inc | 2019-07-22 | 4,186,243 | 24.46 | 102,395,504 |
ARDX | Ardelyx Inc | 2021-12-15 | 10,752,012 | 6.42 | 69,027,917 |
KRRO | Korro Bio Inc | 2024-04-22 | 1,090,793 | 62.93 | 68,643,603 |
AVEO | AVEO Pharmaceuticals Inc | 2020-06-19 | 3,952,958 | 15.00 | 59,294,370 |
AKUS | Akouos Inc | 2020-06-30 | 4,294,207 | 13.29 | 57,070,011 |
GRPN | Groupon Inc | 2013-08-15 | 3,709,248 | 11.67 | 43,286,924 |
LQDA | Liquidia Corp | 2018-07-30 | 2,484,870 | 12.53 | 31,135,421 |
TRVI | Trevi Therapeutics Inc | 2022-04-11 | 10,421,428 | 2.78 | 28,971,570 |
MRSN | Mersana Therapeutics Inc | 2020-04-13 | 7,962,710 | 2.94 | 23,410,367 |
INWK | InnerWorkings Inc | 2012-02-29 | 6,029,190 | 2.99 | 18,027,278 |
MM | Millennial Media Inc | 2012-10-29 | 8,196,614 | 1.75 | 14,344,075 |
INZY | Inozyme Pharma Inc | 2020-07-28 | 2,437,689 | 4.44 | 10,823,339 |
EPZM | Epizyme Inc | 2016-01-12 | 6,260,851 | 1.47 | 9,203,451 |
MRKR | Marker Therapeutics Inc | 2021-03-16 | 1,071,429 | 4.29 | 4,596,430 |
SURF | Surface Oncology Inc | 2018-04-23 | 3,312,877 | 1.07 | 3,544,778 |
RGLS | Regulus Therapeutics Inc | 2020-12-04 | 645,106 | 2.42 | 1,561,157 |
EAR | Eargo Inc | 2020-10-20 | 326,001 | 2.57 | 837,823 |
DERM | Dermira Inc | 2014-10-02 | 17,241 | 18.75 | 323,269 |
ILIU | Interleukin Genetics Inc | 2016-07-29 | 55,418,811 | 0.00 | 249,385 |
AKAOQ | Achaogen Inc | 2016-12-19 | 5,215,128 | 0.03 | 130,378 |
CLVSQ | Clovis Oncology Inc | 2011-11-21 | 3,419,671 | 0.02 | 51,295 |
TCON | TRACON Pharmaceuticals Inc | 2018-03-27 | 17,330 | 1.81 | 31,367 |
MTCR | Metacrine Inc | 2021-12-22 | 2,563,257 | 0.00 | 3,589 |
ABIO | ARCA biopharma Inc | 2018-02-26 | 0 | 3.58 | 0 |
GNCAQ | Genocea Biosciences Inc | 2022-05-25 | 0 | 0.00 | 0 |
DATA | Tableau Software Inc | 2016-12-05 | 0 | 169.53 | 0 |
ARYX | ARYx Therapeutics Inc | 2011-03-10 | 0 | 0.00 | 0 |
APPN | Appian Corp | 2017-11-27 | 0 | 37.56 | 0 |
Holding Weightings of Forest Baskett
Forest Baskett Form 4 Trading Tracker
According to the SEC Form 4 filings, Forest Baskett has made a total of 1 transactions in Robinhood Markets Inc (HOOD) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Robinhood Markets Inc is the sale of 2,082 shares on January 31, 2022, which brought Forest Baskett around $29,606.
According to the SEC Form 4 filings, Forest Baskett has made a total of 0 transactions in Tesaro Inc (TSRO) over the past 5 years. The most-recent trade in Tesaro Inc is the acquisition of 145,532 shares on March 6, 2018, which cost Forest Baskett around $8 Million.
According to the SEC Form 4 filings, Forest Baskett has made a total of 0 transactions in iShares Indl/Office Real Estate Capped (FNIO) over the past 5 years. The most-recent trade in iShares Indl/Office Real Estate Capped is the sale of 3,881 shares on May 1, 2012, which brought Forest Baskett around $99,975.
More details on Forest Baskett's insider transactions can be found in the Insider Trading History of Forest Baskett table.Insider Trading History of Forest Baskett
- 1
Forest Baskett Trading Performance
GuruFocus tracks the stock performance after each of Forest Baskett's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Forest Baskett is 8.99%. GuruFocus also compares Forest Baskett's trading performance to market benchmark return within the same time period. The performance of stocks bought by Forest Baskett within 3 months outperforms 31 times out of 54 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Forest Baskett's insider trading performs compared to the benchmark.
Performance of Forest Baskett
Average Return
-19.48%
Outperforming Transactions
23%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 6.61 | 8.99 | 7.4 | -19.48 | -30.7 | -26.93 |
Relative Return to S&P 500(%) | 5.73 | 5.77 | 0.37 | -33.74 | -41.83 | -40.35 |
Forest Baskett Ownership Network
Ownership Network List of Forest Baskett
Ownership Network Relation of Forest Baskett
Forest Baskett Owned Company Details
What does Eargo Inc do?
Who are the key executives at Eargo Inc?
Forest Baskett is the 10 percent owner of Eargo Inc. Other key executives at Eargo Inc include Chief Accounting Officer Mark Thorpe , Chief Operating Officer William Brownie , and Chief Financial Officer Adam Laponis .
Eargo Inc (EAR) Insider Trades Summary
Over the past 18 months, Forest Baskett made no insider transaction in Eargo Inc (EAR). Other recent insider transactions involving Eargo Inc (EAR) include a net sale of 2,012 shares made by William Brownie , a net sale of 725 shares made by Adam Laponis , and a net sale of 92 shares made by Mark Thorpe .
In summary, during the past 3 months, insiders sold 0 shares of Eargo Inc (EAR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,799 shares of Eargo Inc (EAR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,799 shares.
Eargo Inc (EAR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eargo Inc Insider Transactions
Forest Baskett Mailing Address
Above is the net worth, insider trading, and ownership report for Forest Baskett. Currently GuruFocus does not have mailing address information for Forest Baskett.